Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Aug 28;258:118350. doi: 10.1016/j.lfs.2020.118350

Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study” [Life Sci. 253 (2020) 117592]

Abdo A Elfiky 1
PMCID: PMC7957227  PMID: 32863005

The author regrets that the article omitted to clarify that parts of Sections 2.1, 2.2, 3.1 and 3.2, as well as of Figs. 1 and 2 were reused from the article that was previously published by the author in Life Sciences 248 (2020) 117477 https://doi.org/10.1016/j.lfs.2020.117477.

The author would like to apologise for any inconvenience caused.


Articles from Life Sciences are provided here courtesy of Elsevier

RESOURCES